Literature DB >> 8069398

Immunoaffinity purification of recombinant hepatitis B surface antigen from yeast using a monoclonal antibody.

A Agraz1, C A Duarte, L Costa, L Pérez, R Páez, V Pujol, G Fontirrochi.   

Abstract

A murine monoclonal antibody developed for the purification of recombinant hepatitis B surface antigen was immobilized on a chromatographic support and used to adsorb and purify the recombinant antigen from yeast. The adsorption-elution behaviour was first investigated using monoclonal antibody-coated enzyme-linked immunosorbent assay plates and performing adsorption, washing and elution procedures with different elution agents. It was found that 3 M KSCN and 8 M urea at neutral pH disrupted antigen-antibody interactions in both systems. The procedure for washing the immunoaffinity column was optimized, using different salts and detergents. The best results were obtained by applying the starting material in 1 M NaCl and washing with the same buffer. The use of 0.1% sodium deoxycholate in the washing buffer reduced about 20-fold lipopolysaccharide contamination in the eluates as compared with washing without detergent. The relationship between bed height and the adsorption capacity of the column was studied, and it was found that the dynamic capacity decreased twice on reducing its length/diameter ratio tenfold. The recovery of antigen was not affected by increasing the flow-rate up to 25 cm/h but decreased at higher values. Using the optimum conditions, the affinity column was able to purify the recombinant hepatitis B surface antigen to more than 90% purity and a 65% antigen recovery was obtained.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069398     DOI: 10.1016/0021-9673(94)80591-1

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  Tobacco seeds as efficient production platform for a biologically active anti-HBsAg monoclonal antibody.

Authors:  Abel Hernández-Velázquez; Alina López-Quesada; Yanaysi Ceballo-Cámara; Gleysin Cabrera-Herrera; Kenia Tiel-González; Liliana Mirabal-Ortega; Marlene Pérez-Martínez; Rosabel Pérez-Castillo; Yamilka Rosabal-Ayán; Osmani Ramos-González; Gil Enríquez-Obregón; Ann Depicker; Merardo Pujol-Ferrer
Journal:  Transgenic Res       Date:  2015-06-25       Impact factor: 2.788

2.  Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants.

Authors:  Nadia Ramírez; Marta Ayala; Damaryst Lorenzo; Daniel Palenzuela; Lissett Herrera; Vivian Doreste; Marlene Pérez; Jorge V Gavilond; Pedro Oramas
Journal:  Transgenic Res       Date:  2002-02       Impact factor: 2.788

3.  Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.

Authors:  Ulrik H Mistarz; Susheel K Singh; Tam T T N Nguyen; Will Roeffen; Fen Yang; Casper Lissau; Søren M Madsen; Astrid Vrang; Régis W Tiendrebeogo; Ikhlaq H Kana; Robert W Sauerwein; Michael Theisen; Kasper D Rand
Journal:  Pharm Res       Date:  2017-06-23       Impact factor: 4.200

4.  Chromatographic removal combined with heat, acid and chaotropic inactivation of four model viruses.

Authors:  R Valdés; Neysi Ibarra; I Ruibal; A Beldarraín; E Noa; N Herrera; R Alemán; S Padilla; J Garcia; M Pérez; R Morales; E Chong; B Reyes; Y Quiñones; A Agraz; L Herrera
Journal:  J Biotechnol       Date:  2002-07-03       Impact factor: 3.307

5.  Progress in affinity ligand-functionalized bacterial magnetosome nanoparticles for bio-immunomagnetic separation of HBsAg protein.

Authors:  Leila Hatami Giklou Jajan; Seyed Nezamedin Hosseini; Mohsen Abolhassani; Masoud Ghorbani
Journal:  PLoS One       Date:  2022-07-25       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.